Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis

[1]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[2]  J. Berkhof,et al.  The health and economic effects of HPV DNA screening in The Netherlands , 2010, International journal of cancer.

[3]  G. Ronco,et al.  Age‐specific patterns of unsatisfactory results for conventional Pap smears and liquid‐based cytology: data from two randomised clinical trials , 2010, BJOG : an international journal of obstetrics and gynaecology.

[4]  N. Segnan,et al.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Marc Arbyn,et al.  Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. , 2009, JAMA.

[6]  J. Habbema,et al.  Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. , 2009, Journal of the National Cancer Institute.

[7]  V. Kuenen-Boumeester,et al.  Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program. , 2009, Gynecologic oncology.

[8]  L. Massuger,et al.  Cytologic Detection of Cervical Abnormalities Using Liquid-Based Compared With Conventional Cytology: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.

[9]  Marc Arbyn,et al.  Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis , 2008, Obstetrics and gynecology.

[10]  J. Habbema,et al.  Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies , 2007, International journal of cancer.

[11]  M. Mohammed,et al.  The impact of the introduction of liquid based cytology on the variation in the proportion of inadequate samples between GP practices , 2007, BMC public health.

[12]  A. Herbert,et al.  European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[13]  Les Irwig,et al.  Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study , 2007, BMJ : British Medical Journal.

[14]  M Arbyn,et al.  European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid‐based cytology * , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[15]  S. Wacholder,et al.  Risk of Precancer and Follow-up Management Strategies for Women With Human Papillomavirus–Negative Atypical Squamous Cells of Undetermined Significance , 2007, Obstetrics and gynecology.

[16]  J. Cuzick,et al.  Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial , 2007, BMJ : British Medical Journal.

[17]  M. van Ballegooijen,et al.  Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the netherlands , 2007, International journal of cancer.

[18]  J. Roberts,et al.  A three‐armed trial of the ThinPrep Imaging System , 2007, Diagnostic cytopathology.

[19]  M. Desai,et al.  Liquid‐based cytology can improve efficiency of cervical smear readers: evidence from timing surveys in two NHS cytology laboratories , 2006, Cytopathology : official journal of the British Society for Clinical Cytology.

[20]  M. Ziol,et al.  Cost‐effectiveness of liquid‐based cytology with or without hybrid‐capture II HPV test compared with conventional Pap smears: A study by the French society of clinical cytology , 2005, Diagnostic cytopathology.

[21]  L. Irwig,et al.  Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review , 2006, The Lancet.

[22]  M. Quinn,et al.  An alternative cost effectiveness analysis of ThinPrep in the Australian setting , 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

[23]  W. Gerth,et al.  Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[24]  J Chilcott,et al.  Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. , 2004, Health technology assessment.

[25]  Joakim Dillner,et al.  Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. , 2004, Journal of the National Cancer Institute.

[26]  W. Lawrence,et al.  Benefits and costs of using HPV testing to screen for cervical cancer. , 2002, JAMA.

[27]  J. Habbema,et al.  Cost-effectiveness of cervical cancer screening: comparison of screening policies. , 2002, Journal of the National Cancer Institute.

[28]  J. Walboomers,et al.  Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: The age‐related patterns for high‐risk and low‐risk types , 2000, International journal of cancer.

[29]  M. Ballegooijen.  Effects and Costs of Cervical Cancer Screening , 1998 .

[30]  H. Adami,et al.  International incidence rates of invasive cervical cancer after introduction of cytological screening , 1997, Cancer Causes & Control.

[31]  J D Habbema,et al.  The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.

[32]  R Legood,et al.  MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. , 2011, Health technology assessment.

[33]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.